PF-04895162
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-04895162, covering 2013-03-28 to 2013-03-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162 [Phase 1]